Perrin C White, MD
University of Texas Southwestern Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Perrin C White, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:26 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT03548246 · Androgen Reduction in Congenital Adrenal HyperplasiaUniversity of Texas Southwestern Medical Center · withdrawn · Congenital Adrenal Hyperplasia · principal investigator
- Ph1NCT02574910 · Androgen Reduction in Congenital Adrenal Hyperplasia, Phase 1University of Texas Southwestern Medical Center · terminated · Congenital Adrenal Hyperplasia · principal investigator
- Ph1NCT00962026 · Rilonacept in Diabetes Mellitus Type 1: Safety StudyUniversity of Texas Southwestern Medical Center · completed · Type 1 Diabetes Mellitus · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:26 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Abiraterone Acetate in Childen with Classic 21-Hydroxylase DeficiencyU01HD083493 · NICHD · UT SOUTHWESTERN MEDICAL CENTER · PI PERRIN C WHITE · fiscal years 2015 to 2020Named on NCT02574910
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.